You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ULTRACET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ultracet patents expire, and what generic alternatives are available?

Ultracet is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ULTRACET is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.

Summary for ULTRACET
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 26
Formulation / Manufacturing:see details
Drug Prices: Drug price information for ULTRACET
What excipients (inactive ingredients) are in ULTRACET?ULTRACET excipients list
DailyMed Link:ULTRACET at DailyMed
Drug patent expirations by year for ULTRACET
Drug Prices for ULTRACET

See drug prices for ULTRACET

Recent Clinical Trials for ULTRACET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 4
Gia Dinh People HospitalN/A
The Catholic University of KoreaN/A

See all ULTRACET clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ULTRACET

US Patents and Regulatory Information for ULTRACET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms ULTRACET acetaminophen; tramadol hydrochloride TABLET;ORAL 021123-001 Aug 15, 2001 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ULTRACET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms ULTRACET acetaminophen; tramadol hydrochloride TABLET;ORAL 021123-001 Aug 15, 2001 ⤷  Try a Trial ⤷  Try a Trial
Janssen Pharms ULTRACET acetaminophen; tramadol hydrochloride TABLET;ORAL 021123-001 Aug 15, 2001 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ULTRACET

See the table below for patents covering ULTRACET around the world.

Country Patent Number Title Estimated Expiration
Singapore 80535 COMPOSITION COMPRISING A TRAMADOL MATERIAL AND ACETAMINOPHEN AND ITS USE ⤷  Try a Trial
Luxembourg 91079 ⤷  Try a Trial
Hungary 219332 Transz-(+)-2-[(dimetil-amino)-metil]-1-(3-metoxi-fenil)-ciklohexanolt és acetaminofent tartalmazó szinergetikus gyógyszerkészítmények (SYNERGETIC MEDICAMENTS CONTAINING TRANS-(+)-2-[(DIMETHYLAMINO)-METHYL]-1-(3-METHOXIPHENYL)-CYCLOHEXANOL AND ACETAMINOPHEN) ⤷  Try a Trial
Japan 3381190 ⤷  Try a Trial
China 1071571 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ULTRACET

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0566709 300152 Netherlands ⤷  Try a Trial 300152, 20120903, EXPIRES: 20170404
0566709 SPC/GB04/012 United Kingdom ⤷  Try a Trial PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
0566709 C300152 Netherlands ⤷  Try a Trial PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
0566709 SPC023/2008 Ireland ⤷  Try a Trial SPC023/2008: 20090921, EXPIRES: 20170404
0566709 91079 Luxembourg ⤷  Try a Trial 91079, EXPIRES: 20170903
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.